The hemodynamic function of the thin-wall, glutaraldehyde-treated porcine xenograft was evaluated in 37 asymptomatic patients an average of 8 months (range 6-15 months) after operation. Three patients had a double-valve replacement. Cardiac output and simultaneous transvalvular gradients were recorded at rest and during moderate supine exercise. In 25 patients with an aortic bioprosthesis, the average mean gradient was 18 mm Hg and the effective orifice area 1.5 cm' (range 0.5-2.8 cm2). The average aortic valve area for seven patients with a small valve (21 or 23 mm) was 1.2 cm'. During exercise, the mean gradient increased to 23 mm Hg (range 7-36 mm Hg) and the effective orifice area increased to 1.8 cm2 (range 1.0-3.8 cm2). In 15 patients with a mitral bioprosthesis, the average diastolic gradient was 6 mm Hg and the effective orifice area 2.4 cm2 (range 1.4-3.9 cm2). The average mitral valve area for 10 patients with a 27or 29-mm valve was 2.1 cm2. During exercise, the mean gradient increased to 14 mm Hg (range 6-32 mm Hg) and the effective orifice area increased to 2.8 cm2 (range 1.5-4.8 cm2). Of the 40 valves evaluated, three had mild and one had moderate regurgitation. We conclude that the Carpentier-Edwards valve has hemodynamic characteristics similar to those of other currently used prostheses.
THE GLUTARALDEHYDE-FIXED porcine xenograft is being implanted more often because of decreased risk of thromboembolism in the absence of systemic anticoagulation,1-10 absence of hematological abnormalities,1' silent function and satisfactory hemodynamic performance.2-18 However, there continues to be concern over the durability of bioprostheses, because structural changes occur in the valve tissue over time, 19 -21 and long-term clinical experience is limited. Several reports have indicated that the porcine xenograft is moderately obstructive in the smaller annulus sizes. 14-16 22, 23 The Carpentier-Edwards bioprosthesis has a reduced stent width that provides a larger orifice-to-annulus ratio; the stent is slightly asymmetric to accommodate the muscular shelf. Few hemodynamic data are available for the Carpentier-Edwards glutaraldehyde-treated porcine xenograft and it is not known whether the above modifications have indeed increased the effective orifice area, especially in the smaller valve sizes. In the present study, the hemodynamic function of the Carpentier-Edwards bioprosthesis was assessed in 37 patients an average of 8 months after operation.
Direct transvalvular pressure measurements were recorded at rest and during moderate supine exercise. e F~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~.. FIGURE 1. Three current glutaraldehydetreated porcine xenografts. The partially obstructive muscular ridge (M) is easily seen. See text for discussion.
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: ; ttc the valve and decrease the amount of obstructive muscle tissue in the orifice. The porcine aortic valve tissue is tanned in 0.625% glutaraldehyde solution. The Carpentier-Edwards valve differs from the Hancock and Angell-Shiley valve in that the stent is thinner, the valve tissue is tanned in slightly more concentrated glutaraldehyde solution, and the obstructive muscular portion of the right coronary leaflet has been incorporated into the stent.
Patients
Between May 1976 and July 1978, six surgeons implanted 368 prosthetic valves in 326 patients at the Montreal Heart Institute; 54 valves were tilting-disc prostheses and 314 were bioprostheses. The population evaluated in this study consisted of all 175 patients who received 202 Carpentier-Edwards porcine xenografts. Eighty-two patients had an aortic valve replacement, 66 a mitral valve replacement and 27 patients had both mitral and aortic valve replacement. By July 1978, 90 patients had had a 6-month follow-up; 79 were asymptomatic or dyspneic only on severe exertion. Thirty-seven of the 79 patients agreed to undergo cardiac catheterization, which was performed an average of 8 months (range 6-15 months) postoperatively. The hemodynamic protocol was accepted by the Human Subjects Research Committee and informed consent was obtained from each patient before the catheterization. There were no complications as a result of catheterization. The mean age of the 37 patients was 47 years (range 23-63 years); there were 26 men and 11 women. Five patients had associated coronary bypass procedures. In the absence of a major contraindication, all patients received anticoagulants. Anticoagulation was terminated at 2 months unless there was marked left atrial dilatation, chronic atrial fibrillation or a history of embolic events. The patients who underwent cardiac catheterization were selected by the absence of significant symptoms in order to establish baseline values for the normal in vivo hemodynamic function of this bioprosthesis. The range of annulus sizes studied is shown in tables I and 2. Of the 109 aortic bioprostheses implanted, 22% (eight of 36) of the 21and 23-mm stent sizes, 19% (11 of 59) of the 25and 27-mm stent sizes and 43% (six of 14) of the 29and 31-mm stent sizes were evaluated by cardiac catheterization. Of the 93 mitral bioprostheses implanted, 23% (10 of 43) of the 27and 29-mm stent sizes and 10% (five of 50) of the 31and 33-mm stent sizes were evaluated by catheterization.
Surgical Technique
The technique of valvular replacement used in this study included cardiopulmonary bypass with a bubble oxygenator, hemodilution, systemic hypothermia (22°C) and aortic clamping, Myocardial protection was achieved through repeated (every [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] minutes) injection of cold potassium solution* in the coronary ostia or the aortic root. These injections maintain electrical standstill and a myocardial temperature of 13-18°C. The pericardial cavity is concomitantly irrigated with cold saline solution. The heart is defibrillated immediately after unclamping of the aorta and allowed to beat in total bypass until fully rewarmed. This minimizes left ventricular work during the critical period of coronary reperfusion, as the aortic valve remains closed; decompression of the left ventricle is *Content of cardioplegic solution: Each 100 ml of Ringers lactate contains 5 g glucose, 2.5 g mannitol, 180 mg NaHCO,, 179 mg KCI, maintained through the vent introduced via the right superior pulmonary vein. The mitral valve is resected en bloc with the chordae and the fibrous tip of the papillary muscles. One strut of the prosthesis is sewn in line with the anterolateral commissure and the widest interstrut space is allowed to face the left ventricular outflow tract. About 15 #0 Mersilene stitches are inserted in a mattress fashion on the prosthesis and in figure-of-eight in the valve annulus. Once the prosthesis is lowered into position, a laryngeal mirror is passed through the center of the prosthesis into the left ventricle to detect suture looping of a strut. This maneuver is not necessary in aortic valve replacement, during which suture tails are kept short to avoid screening of the coronary ostia. Single interrupted sutures are used in small aortic orifices (. 23 mm) to facilitate lowering of the prosthesis and avoid the annular constriction inherent to the use of figure-of-eight stitches. For the small annulus also, the proper size of the prosthesis is the one that fits the annulus as measured with the obturator sitting on the valvular ring and not pushed into the left ventricle. Introducing the obturator into the left ventricle usually requires a smaller instrument.
Cardiac Catheterization
Postoperative hemodynamic studies were carried out with patients in the fasting state after light sedation with oral diazepam. Diazepam was administered orally, because parenteral administration causes a slight decrease in systemic and left ventricular enddiastolic pressures.24 Right-and left-heart catheterizations were done using standard catheterization techniques. In all patients, a Lehman catheter was positioned in the main pulmonary artery, a Brockenbrough transseptal catheter in either the left atrium or left ventricle and a Bourassa polyethylene catheter in either the ascending aorta or left ventricle. Patients AM-1, AM-2 and AM-3 had mitral and aortic bioprostheses. Patients AM-2 and AM-3 had left ventricular pressures registered through an 18-gauge, 15- cm-long teflon catheter introduced into the left ventri-1173 VOL 60, No Mean gradients were determined by hand planimetry of five diastolic cycles. The Statham P23Db transducers were equilibrated at the mid-chest position. Pressures were registered through a Hewlett-Packard amplifier #8805C and recorded on a Honeywell recorder using photographic paper. Cardiac output was measured by the indicator-dilution technique using the average of two separate injections of indocyanine green contrast material injected into the main pulmonary artery and sampled from the central aorta. Pressures and cardiac output measurements were recorded at rest and during moderate supine arm exercise against 50 watts resistance. All but five patients, three of whom had mitral and aortic valve bioprostheses, performed the exercise protocol. Uniplane left ventricular cineangiograms were obtained in the 30°right anterior oblique position. Supra-aortic contrast angiography was performed in the 900 left lateral position. The average postoperative ejection fraction calculated by the area-length method25 was 0.57. One patient (M-9) had an ejection fraction < 0.35.
Valve orifice areas were calculated from the Gorlin formula26 using mean gradients. The Gorlin formula for valve area presupposes a constant flow rate through the cardiac cycle, but we observed small mean prosthetic gradients that were largely related to uneven flow rates. In some patients, pressures equilibrated during the cardiac cycle after the early rapid flow phase of cardiac contraction. The use of the Gorlin formula to calculate effective orifice area under these hemodynamic conditions is difficult and may not precisely reflect the in vivo bioprosthetic valve area. A constant of 44.5 was used for aortic bioprostheses and 31 for mitral bioprostheses. We used a constant of 31 for the mitral valve bioprosthesis rather than 38, which is slightly more accurate,27' 28 in order to facilitate comparison of our results to previously reported data. The preoperative catheterization values for patients with stenotic valves were included in tables 1 and 2 for postoperative hemodynamic comparison. Statistical 
Results
The hemodynamic data for the 37 patients are shown in tables 1 and 2. Data from patients AM-1, AM-2 and AM-3, who had mitral and aortic valve replacements, are presented in both tables. There was a significant hemodynamic improvement in almost all patients after operation. A comparison of preoperative catheterization data with that obtained in the same patients postoperatively revealed a decrease in aortic mean gradient (64 ± 7.7 to 19 ± 2.3 mm Hg; p < 0.001), an increase in aortic valve area (0.58 ± 0.06 to 1.4 + 0.13 cm2;p < 0.001), and an increase in aortic valve area indexed for body surface area (0.33 ± 0.03 to 0.77 + 0.07 cm2/m2; p < 0.001). In patients with a mitral valve replacement, the mean gradient decreased (13 + 4.2 to 6 ± 0.9 mm Hg; NS), the mitral valve area increased (1.15 ± 0.15 to 2.54 ± 0.4 cm2; p < 0.05) and the mitral valve area index increased (0.63 + 0.07 to 1.4 ± 0.21 cm2/m2; p < 0.05).
Rest Catheterization Data

Aortic Valve Bioprosthesis
The average aortic valve area was 1.5 ± 0.1 cm2 for the 25 patients studied. Because the number of valves in each size was small, 21-and 23-mm, 25-and 27mm, and 29-and 3 1-mm valves were grouped together for statistical comparison. The larger valves (29 and 31 mm) had a greater effective orifice area (1.9 ± 0.3 cm2) than the medium-sized (25 and 27 mm) (1.4 i 0.1 cm2; p < 0.05) and smaller valves (21 and 23 mm) (1.2 i 0.1 cm2; p < 0.03). There was considerable scatter in the range of effective orifice areas within each group of stent sizes ( fig. 2 ). Similar results were obtained with calculated aortic valve areas indexed for body surface area. The peak-to-peak aortic gradient was significantly less than the mean aortic PA#75922 Cf31yrs,29mm aortic valve FIGURE 3 . In all patients with an aortic bioprosthesis, the peak-to-peak aortic gradient was less than the mean aortic gradient, as shown in this example (patient A-20). The effective orifice area increased during exercise. Thesefindings indicate minimal leaflet inertia that is overcome in early systole when the valve opens fully. LV = left ventricle; Asc Ao ascending aorta. Vibrations on aortic pressure tracing are artifact. 31, 33 Valve (mm) FIGURE 5. The effective orifice areas ofthe 31-and 33-mm Carpentier-Edwards mitral xenografts tend to be larger than those in the 27-and 29-mm stent sizes (see text).
her hemodynamic data are shown in figure 4 . The resting mean aortic gradients averaged 18 mm Hg (range 5-36 mm Hg).
Of the 25 patients studied, four (16%) had regurgitation graded > 1/4. The regurgitant flow was graded 1/4 in three patients (AM-1, AM-2, and A-20), 2/4 in one (A-4). All four patients had an aortic insufficiency murmur. We could not determine from supravalvular contrast aortography whether the regurgitant flow was transvalvular or paravalvular. Although aortic regurgitation was more frequent in the 21and 23-mm valves, there was no clear-cut relationship between valve size and frequency or severity of regurgitation.
Mitral Valve Bioprosthesis
The average mitral valve area was 2.1 + 0.2 cm2 for the 15 patients evaluated. Because the number of valves in each annulus size was small, 27-and 29-mm, and 31-and 33-mm valves were grouped together for comparison. Patients with the 31-and 33-mm valves tended to have a greater effective mitral orifice area than those with the 27-and 29-mm valves (2.9 ± 0.4 vs 2.1 ± 0.2 cm2; p < 0.1) ( fig. 5 ). The number of catheterized patients, however, with 31-and 33-mm stent sizes was small, and larger numbers are required for greater statistical confidence. Mitral orifice area indexed for body surface area was significantly greater (1.7 ± 0.2 vs 1.2 ± 0.1 cm2/m2; p < 0.05) in the larger stent sizes. The average mitral valve gradient at rest was 7 mm Hg (range 3-10 mm Hg) for the 27-and 29-mm valves and 5 mm Hg (range 3-6 mm Hg) for the 31-and 33-mm valves (NS). Figure 6 shows the hemodynamic data obtained in a patient (M-4) with a 29-mm bioprosthesis. The smallest effective mitral r--|lk"7 6 21,23 25, 27 29, 31 Valve Size (mm) FIGURE 7. The shaded areas indicate the average increase in gradient during exercise. At restingflow rates, the mean aortic valve gradient is unrelated to stent size. A t higherflow rates during exercise, the mean exercise gradient is less in the 29-and 31-mm stent sizes than in the 21-and 23-mm stent sizes (18 vs 28 mm Hg; p < 0.02); the average increases in cardiac output were comparable.
The resting and exercise parameters of these 20 patients were compared. The average cardiac output increased 84% (5.8 to 10.4 I/min; p < 0.001) and
ranged from 72% in the 25-and 27-mm valves to 96% in the 21-and 23-mm valves. Average mean aortic gradient only increased 40% (18 to 23 mm Hg; p < 0.005). There was a lesser increase in exerciseinduced gradient in patients with 29-and 31-mm bioprostheses (17 to 18 mm Hg) than in those with a 25or 27-mm valve (17 to 24 mm Hg) and those with 21or 23-mm bioprostheses (22 to 28 mm Hg) ( fig. 7) . The maximum gradient during exercise was 36 mm Hg in patient A-4, who had a 23-mm bioprosthesis. Three patients paradoxically decreased their gradients during exercise (A-3 shown in figure 3 , A-17 and A-21). The average aortic valve area increased from 1.51 ± 0.1 cm2 to 1.78 ± 0.2 cm2 (p < 0.01) during exercise ( fig. 8 ). The average aortic valve area indexed for body surface area showed a similar increase (0.87 ± 0.1 to 1.02 + 0.1; p <0.01). The effective orifice area increased > 10% in only one of five (20%) of the 21-and 23-mm valves compared with six of nine (67%) of the 25-and 27-mm valves and five of six (83%) of the 29-and 3 1-mm valves (p < 0.01). Similar results were obtained when effective orifice area was indexed for body surface area.
Eleven patients with mitral bioprostheses performed supine arm exercise during the catheterization. Their resting and exercise data were compared. Average cardiac output increased 68% (4.1 to 6.8 l/min;p < 0.001) and ranged from 75% in the 27-and 29-mm valves to 56% in the 31and 33-mm valves. Average mitral valve gradient increased 162% (6 to 15 mm Hg; p < 0.01). The average exercise-induced gradient in patients with a 27or 29-mm valve was 17 mm Hg (range 9-32 mm Hg) and was 11 mm Hg (range 6-14 mm Hg) in patients with a 31or 33-mm valve ( fig. 9 ).
The average mitral valve area increased by about 20% (p < 0.02) ( fig. 8) . The results were similar when '%increase in cardiac output 56% 4 
31,33
Valve Size (mm) FIGURE 9 . The shaded areas indicate the average increase in gradient during exercise. The mitral valve gradient is slightly less in the larger stent sizes, both at rest and during exercise.
Hancock valve was released for clinical use in North America. The glutaraldehyde-treated porcine xenograft has a low embolic rate, does not routinely require long-term systemic anticoagulation, is silent and does not cause hematologic abnormalities.'-19 For these reasons, more and more porcine valves are being implanted. However, long-term durability remains unknown, and moderate gradients have been reported in the smaller annulus sizes. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] 22 The effective orifice area of a porcine xenograft is determined by 1) the manufactured size of the annulus; 2) the width of the prosthesis base; 3) the sewing ring; and 4) the width of the muscular shelf at the base of the right coronary leaflet. To increase the effective orifice area of the porcine xenograft in the smaller valve sizes, several approaches have been devised. In the Hancock modified orifice valve, the obstructive muscular right coronary leaflet is removed from the tissue valve and a new nonmuscular leaflet is sewn onto the stent. The long-term consequences of this modification on the durability of the valve is being evaluated. Preliminary hemodynamic data reported by Craver and colleagues have shown decreased systolic gradients in the 21-mm aortic valve sizes but no significant differences in gradient compared with the 23-mm conventional Hancock aortic valve.29 In the Carpentier-Edwards valve, the width of the prosthesis base has been reduced, providing a larger internal-to-external diameter ratio than other bioprostheses. This modification allows a larger tissue xenograft to be mounted on the stent for each stent size without altering the normal porcine valve anatomy. The annulus is slightly asymmetric rather than circular, which allows the muscle shelf of the right coronary leaflet to be more easily incorporated into the stent. This technique results in less muscle tissue in the orifice and, theoretically, a more effective flow area (fig. 1 ). In this study, we evaluated the hemodynamic results of the above modifications in the Carpentier-Edwards bioprosthesis at rest and dur- The average postoperative aortic valve gradient and area at rest were similar to those reported for other prostheses '3-15, 23, 29-34 (table 3 ). In the smaller valve sizes (21 and 23 mm) the average valve area was 1.2 cm2, which is comparable to values reported for the Hancock bioprosthesis'4-16 and the Ionescu-Shiley bovine xenograft,32 but slightly less than the 1.5 cm2 that Kloster and colleagues reported for the Starr-Edwards model 2310 (9-A)30 and the 1. These differences may be partially due to the population of patients selected for study.
During moderate supine arm exercise, the effective orifice area of the Carpentier-Edwards bioprosthesis increased significantly ( fig. 8) , with the largest increases in the larger valve sizes. Johnson and coworkers'5 reported a rough correlation (r = 0.52) between stroke volume and calculated aortic valve area in 23 patients with Hancock bioprostheses. These findings imply that valve leaflet inertia may be a possible mechanism for low calculated orifice areas of porcine xenografts at low flow rates. This hypothesis is supported by the fact that the peak-to-peak aortic gradient was less than the mean aortic gradient in all patients we studied, demonstrating a small but significant amount of leaflet inertia that must be overcome before the valve opens fully. In the smaller valve sizes (21 and 23 mm), a low flow rate would not completely explain the smaller orifice areas, because calculated valve area only increased in one of five patients with a 21or 23-mm valve during exercise, even though cardiac output doubled. The arm work performed in this study was dynamic and isometric, as patients not only rotated the pedals of the ergometer but also gripped the pedals securely. The increased valve area with exercise may be explained in part by significant rises in left ventricular pressure caused by isometric work as well as increased flow across the valve.
During exercise, the maximum mean aortic gradient was 36 mm Hg, with an average mean gradient of 28 mm Hg for the 21and 23-mm aortic valves. These values are substantially less than the average 51-mm Hg gradient that Jones et al. 16 reported for six patients with 21-mm Hancock bioprostheses and the average 70-mm Hg gradient that Hannah and Reis reported for 10 patients with Hancock bioprostheses.'2 However, it is difficult to compare our results with theirs, because the corresponding percentage increase in cardiac output during exercise was not reported. The Bjork-Shiley valve, which has the largest calculated valve area for the 21-mm valve size, also has a substantial gradient during exercise (48 mm Hg at 10-1/min cardiac output). 3' In our study, three patients had I + and one patient had 2+ aortic regurgitation, an incidence of 16% (four of 25). Morris 
Mitral Valve
The average effective mitral orifice area and diastolic gradient at rest was similar to results published for other prostheses' 3 14, 18, 30, 32 (table 4) . The smallest effective orifice area in the mitral position was 1.54 cm2. These results are similar to those reported for Hancock bioprostheses, although in the series of Johnson et al.'7 and Lurie et al.,'3 two patients had an effective orifice area < 1 cm2. Wiltrakis et al. 22 reported two symptomatic patients with 27-mm Carpentier-Edwards bioprostheses in the mitral position. One patient had a resting gradient of 10 mm Hg and the second a resting gradient of 22 mm Hg. In our three patients with a 27-mm valve, the average gradient was 7 mm Hg and the effective orifice area 1.89 cm2. However, our patients were not 1180 CIRCULATION CARPENTIER-EDWARDS XENOGRAFT/Chaitman et al. 
Characteristics of Mitral
Conclusions
The hemodynamic characteristics of the Carpentier-Edwards bioprosthesis are comparable to those of other currently available bioprostheses. However, like all other prostheses, mechanical or biological, small effective orifice areas are observed in the smaller valve sizes, and a mild functional impairment can result if a small valve is implanted in a large, physically active person. Rahimtoola has stated the problem of valve prosthesis-patient mismatch. 36 When the aortic root is small in a large, active person and the aorta will only accommodate a 21-mm size valve, the Bjdrk-Shiley or Starr-Edwards valve may offer a more satisfactory hemodynamic result than a bioprosthesis. This will not be a common occurrence, because, in our series, only 3% (three of 109) of patients required a 21-mm valve.
In the mitral position, all currently available valves are mildly obstructive and cause moderate gradients during supine exercise. The mechanical prostheses compared in this study do not offer a hemodynamic advantage over the bioprosthesis in adults in the mitral position.
